| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and then buying some of the stock in the $40s.
On Sept. 24, RBC Capital analyst Logan Reich reiterated Dutch Bros with an Outperform and maintained a price target of $85.
American Bitcoin Corp (NASDAQ: ABTC) is a “total spec,” Cramer said.
As per the recent news, American Bitcoin, on Thursday, named KPMG as new auditor.
Recursion Pharmaceuticals (NASDAQ: RXRX) has been a “bad stock. We need to see something good before I tell you I would put any money in it,” Cramer said.
On the earnings front, Recursion reported second-quarter revenue of $19.22 million on August 5, beating analyst estimates of $16.23 million, according to Benzinga Pro. The company reported a second-quarter loss of 41 cents per share, missing forecasts for a loss of 34 cents per share.
Cramer said he needs to see a bounce in Republic Services, Inc. (NYSE: RSG).
On Sept. 19, Barclays analyst William Grippin initiated coverage on Republic Services with an Equal-Weight rating and announced a price target of $240.
Price Action:
Read Next:
Image: Shutterstock
